Article
Clinical prediction based on HPV DNA testing by hybrid capture 2 (HC2) in combination with liquid-based cytology (LBC).
Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2013
Junyangdikul Pairoj, Tanchotsrinon Watcharaporn, Chansaenroj Jira, Nilyaimit Pornjarim, Lursinsap Chidchanok, Poovorawan Yong
Abstract excerpt
Primary screening by HPV DNA testing is an effective method for reducing cervical cancer and has proven more sensitive than cytology. To advance this approach, many molecular methods have been developed. Hybrid capture 2 provides semi-quantitative results in ratios of relative light units and positive cutoff values (RLU/ PC). Twenty-five thousand and five patients were included in this study to analyze the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
